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bstract
Although oxidative stress and the subsequent DNA damage is one of the obligatory signals for poly(ADP-ribose) polymerase
PARP) activation and nuclear factor-kappa B (NFB) alterations, these molecular aspects have not been collectively examined in
pidemiological and clinical settings. Therefore, this study attempts to assess the oxidative DNA damage and its downstream effector
ignals in peripheral blood lymphocytes from Type 2 diabetes subjects without and with microangiopathy along with age-matched
on-diabetic subjects. The basal DNA damage, lipid peroxidation and protein carbonyl content were significantly (p < 0.05) higher
n patients with and without microangiopathy compared to control subjects. Formamido Pyrimidine Glycosylase (FPG)-sensitive
NA strand breaks which represents reliable indicator of oxidative DNA damage were also significantly (p < 0.001) higher in dia-
etic patients with (19.41 ± 2.5) and without microangiopathy (16.53 ± 2.0) compared to control subjects (1.38 ± 0.85). Oxidative
NA damage was significantly correlated to poor glycemic control. PARP mRNA expression and PARP activity were significantly
p < 0.05) increased in cells from diabetic patients with (0.31 ± 0.03 densitometry units; 0.22 ± 0.02 PARP units/mg protein, respec-
ively) and without (0.35 ± 0.02; 0.42 ± 0.05) microangiopathy compared to control (0.19 ± 0.02; 0.11 ± 0.02) subjects. Diabetic
ubjects with and without microangiopathy exhibited a significantly (p < 0.05) higher (80%) NFB binding activity compared to
ontrol subjects. In diabetic patients, FPG-sensitive DNA strand breaks correlated positively with PARP gene expression, PARP
ctivity and NFB binding activity. This study provides a comprehensive molecular evidence for increased oxidative stress and
enomic instability in Type 2 diabetic subjects even prior to vascular pathology and hence reveals a window of opportunity for early
herapeutic intervention.
2007 Elsevier Ltd. All rights reserved.
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1. Introduction
A growing body of evidence suggests that hyper-dative DNA damage and augmentation of poly(ADP-ribose)
e 2 diabetes and microangiopathy, International Journal of
4.013
glycemia associated with increased oxidative and
nitrosative stress is linked to the pathogenesis of
diabetic vascular complications (Evans, Goldfine,
Maddux, & Grodsky, 2002). Although reactive oxy-
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gen species (ROS) damage all macromolecules such
as lipids, proteins and nucleic acids, DNA is one of
the most biologically significant targets of oxidative
attack. Increased superoxide generation accompanied
by increased nitric oxide generation, favors the for-
mation of strong oxidant peroxynitrate (OONO−),
which in turn activates nuclear transcription factor
(NFB) and damages DNA. Excessive DNA dam-
age is an obligatory stimulus for the over-activation
of the nuclear enzyme poly(ADP-ribose) polymerase
(PARP), which in turn depletes intracellular NAD+,
thus slowing the rate of glycolysis, electron transport,
ATP formation and produces ADP ribosylation of many
proteins. These processes result in acute endothelial
dysfunction in diabetic blood vessels contributing to
the development of diabetic complications (Ceriello,
2003).
While there are lots of experimental data to sup-
port various oxidative mechanisms, their relevance to
clinical diabetes is still largely unexplored. The new
concept of oxidative stress, being an important trig-
ger in the onset and progression of diabetes and its
complications, is often challenged because intervention
studies with classic antioxidants, such as vitamin E,
failed to demonstrate any convincing beneficial effects
on cardiovascular outcomes. However, these studies
point out several flaws in the trials among which much
emphasis is on the need for measurement of markers
of oxidation to assess the degree of oxidative stress.
Among various types of DNA base modifications, 8-
hydroxy deoxyguanosine (8-OHdG) has been the most
widely studied and is considered as a key biomarker
of oxidative DNA damage (Hinokio et al., 1999; Shin
et al., 2001). Studies have also shown that activation
of PARP and NFB affects glucose utilization, tran-
scriptional regulation and gene expression via multiple
mechanisms, thus indicating PARP/NFB interface as
a novel drug target for therapeutic intervention (Hassa
& Hottiger, 2002; Pacher, Obrosova, Mabley, & Szabo,
2005). Since cellular systems under physiological con-
dition are protected by an efficient DNA repairing
machinery, we hypothesize that (a) an increase in DNA
damage would be demonstrated in subjects with dia-
betes and its vascular complications and (b) studying
downstream effectors of DNA damage (PARP/NFB)
in a clinical setting could provide an additional link
between molecular intricacies of oxidative stress and
the pathogenesis of diabetes and/or its vascular com-Please cite this article in press as: Adaikalakoteswari, A., et al., Oxi
polymerase/nuclear factor-kappa B signaling in patients with Typ
Biochemistry and Cell Biology (2007), doi:10.1016/j.biocel.2007.0
plications. To test our hypothesis, we assessed the
extent of oxidative damage and its relationship to PARP
and NFB modulation in diabetes and microangiopa-
thy along with measurements of glycemic and lipid PRESS
Biochemistry & Cell Biology xxx (2007) xxx–xxx
status in clinically well-characterized groups of sub-
jects.
2. Materials and methods
2.1. Sample selection
Study subjects were recruited from the Chen-
nai Urban Rural Epidemiology Study (CURES), a
population-based study in Chennai (formerly Madras) in
Southern India. The methodology of CURES has been
published elsewhere (Deepa, Pradeepa, & Rema, 2003;
Rema, Mohan, Deepa, & Ravikumar, 2004). Details such
as age, sex and in diabetic subjects, duration of dia-
betes and other details of diabetic therapy were recorded
and clinical examination was done in all subjects. Sub-
jects undiagnosed for diabetes underwent oral glucose
tolerance tests (OGTT) using 75 g of oral glucose load
(dissolved in 250 ml of water). Those who were con-
firmed by OGTT to have 2 h plasma glucose value
<7.8 mmol/l (140 mg/dl) were categorized as normal
glucose tolerance (NGT) and those with 2 h plasma glu-
cose value >7.8 mmol/l (140 mg/dl) and <11.1 mmol/l
(200 mg/dl) were categorized as impaired glucose toler-
ance (IGT). Diabetics were diagnosed as per the WHO
criteria. For the present study we randomly selected
(using computer generated random numbers) 40 NGT
subjects and 40 diabetic subjects each with and without
microangiopathy.
Microangiopathy was diagnosed if nephropathy
and/or retinopathy were present. Nephropathy was diag-
nosed if the patients had either persistent proteinuria
(≥500 mg/day) or persistent microalbuminuria (if albu-
minuria estimated by albumin creatinine ratio (ACR)
exceeded 30g/mg of creatinine) in the absence of
urinary tract infection (Mohan et al., 2000; Varghese,
Deepa, Rema, & Mohan, 2001). Retinopathy was
assessed using stereoscopic color retinal photography
as described earlier (Rema et al., 2004). Briefly, the
pupils were dilated using one drop each of phenyle-
pherine 10% and tropicamide 1% into both eyes and
the drops were repeated until the best possible mydri-
asis was obtained. A trained photographer carried out
four-field color retinal photography with a Zeiss FF
450 plus camera using 35 mm color transparencies.
The photographs were graded against standard pho-
tographs of the Early Treatment Diabetic Retinopathy
Study (ETDRS) grading system for severity of retinopa-dative DNA damage and augmentation of poly(ADP-ribose)
e 2 diabetes and microangiopathy, International Journal of
4.013
thy. Hypertension was diagnosed if the subjects had
been treated with antihypertensive drugs or had systolic
blood pressure (SBP) ≥ 140 mmHg or diastolic blood
pressure (DBP) ≥ 90 mmHg. Diabetic subjects without
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icroangiopathy were selected on the basis of absence
f retinopathy (on retinal photography) or nephropathy
24 h protein excretion <100 mg/day and urinary albu-
in levels <30g/mg creatinine). They also had no
istory of angina or myocardial infarction and had nor-
al 12 lead resting ECGs and normal peripheral Doppler
tudies. Informed consent was obtained from all study
ubjects and the institutional ethics committee approved
he study.
.2. Clinical and biochemical characterization
Physical examination included height, weight, waist
nd hip measurements using standardized techniques.
lood pressure was recorded in the right arm with a
ercury sphygmomanometer (Diamond Deluxe Blood
ressure apparatus, Pune, India) while the patients
ere seated. Two readings were taken 5 min apart
nd the mean of the two was taken as the blood
ressure. A fasting blood sample was taken and
erum separated and stored at −70 ◦C until the assays
ere performed. Biochemical analyses were done on
itachi-912 Autoanalyser (Hitachi, Germany) using
its supplied by Roche Diagnostics (Mannheim, Ger-
any). Fasting plasma glucose (GOD–POD method),
erum cholesterol (CHOD–PAP method), serum triglyc-
rides (GPO–PAP method) and HDL cholesterol (Direct
ethod–polyethylene glycol-pretreated enzymes) were
easured. Low-density lipoprotein (LDL) cholesterol
as calculated using the Friedewald formula. Glycated
aemoglobin (HbA1C) was estimated by high-pressure
iquid chromatography using the Variant machine (Bio-
ad, Hercules, CA, USA). Informed consent was
btained from all study subjects and the study was con-
ucted in compliance with the Helsinki Declaration and
pproved by the institutional ethics committee of the
adras Diabetes Research Foundation.
.3. Assessment of intima-medial thickness (IMT)
Intima-media thickness (IMT) of the carotid arter-
es was determined using a high resolution B mode
ltrasonography system (logic 400 GE, Milwaukee,
I, USA) having an electrical linear higher frequency
ransducer (7.5 MHz) as described previously (Mohan,
avikumar, ShanthiRani, & Deepa, 1998).
.4. Isolation of peripheral blood LymphocytesPlease cite this article in press as: Adaikalakoteswari, A., et al., Oxi
polymerase/nuclear factor-kappa B signaling in patients with Typ
Biochemistry and Cell Biology (2007), doi:10.1016/j.biocel.2007.0
Twelve milliliters of fasting peripheral blood was col-
ected from each subject. Two milliliters was used to
ollect plasma and perform lipid and protein oxidation PRESS
Biochemistry & Cell Biology xxx (2007) xxx–xxx 3
assays. The rest was compartmentalized for lympho-
cyte isolation and to perform Comet, PARP activity and
NFB–EMSA (5 ml) and PARP mRNA profiling (5 ml).
Lymphocyte isolation was performed as per our previous
protocol (Balasubramanyam, Kimura, Aviv, & Gardner,
1993). Briefly, freshly collected peripheral blood was
diluted (1:1) with phosphate buffer saline (PBS) and
carefully layered on Histopaque-1077 (Sigma–Aldrich,
India) gradient and centrifuged at 1600 rpm for 30 min.
The buffy-coat interface representing peripheral blood
lymphocytes was aspirated, washed three times in PBS
(pH 7.4) and used for various studies. FPG-sensitive
DNA damage assessment, PARP mRNA expression and
activity and NFB binding assay were determined in
a subset of randomly selected subjects (n = 20 in each
category).
2.5. Comet assay
DNA strand breaks and FPG-sensitive sites were
detected in peripheral blood lymphocytes by single cell
gel electrophoresis, the comet assay (Singh, McCoy,
Tice, & Schneider, 1988). Clear microscope slides
were pre-coated with 1% normal melting agarose. For
each slide, 100l of cell suspension (approximately
10,000 cells) was mixed with 200l of 0.5% low melting
point agarose, spotted as first layer onto the pre-coated
slide and covered with a coverslip. After agarose solid-
ification the coverslip was gently removed; a second
layer of 200l of normal melting agarose (NMA) was
added over the first layer, covered with a coverslip and
allowed to solidify. Cover slips were removed and slides
were placed in chilled lysis buffer (2.5 M NaCl, 100 mM
EDTA, 10 mM Tris–HCl; pH 10, 1% Triton X-100 and
10% DMSO added just before use) at 4 ◦C for 1 h. After
lysis, the slides were placed on the platform in an elec-
trophoresis tank that contains the pre-chilled (4 ◦C for
at least 1 h) electrophoresis solution (300 mM NaOH,
1 mM EDTA, pH 13). The buffer should just barely
cover the slides and was incubated for 30 min at 4 ◦C
before beginning electrophoresis. The electrophoresis
was subsequently conducted at 25 V constant voltage
and 300 mA for 30 min. Then slides were removed from
electrophoresis apparatus and washed with three changes
of neutralization buffer in staining jar for 5 min each at
4 ◦C. Each slide was stained with 75l of ethidium bro-
mide (20g/ml) and covered with a cover slip. The slides
were examined under a fluorescent microscope and ana-dative DNA damage and augmentation of poly(ADP-ribose)
e 2 diabetes and microangiopathy, International Journal of
4.013
lyzed within 3–4 h. Slides were scored using an image
analysis system (Comet Imager 1.2.13) attached to a
fluorescent microscope (Carl-Zeiss, Germany) equipped
with appropriate filter. The microscope was connected to
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a computer through a charge coupled device (CCD) cam-
era to transport images to software for analysis. The final
magnification was 400×. Analysis of mean % DNA in
the tail, one of the reliable indicators of DNA damage
was done using image analysis software. Images from
50 cells (25 from each duplicate slide) were analyzed.
To show the reproducibility of our method, we mea-
sured DNA damage in peripheral blood lymphocytes
from eight subjects on two different occasions. For this,
blood samples were taken twice from the same subject
on two different occasions; the respective samples were
used for the comet assay and checked for correlation
(r = 0.87) and significance (p < 0.001).
2.6. Detection of FPG-sensitive sites (oxidative
DNA damage)
Additional DNA breaks formed at sites containing
8-oxo-deoxyguanosine were detected by incubating the
DNA with the enzyme Formamido Pyrimidine Glycosy-
lase (FPG) (Collins, Duthie, & Dobson, 1993). After the
lysis step in the comet assay, the slides with and without
FPG treatment were washed three times (for 5 min each)
in enzyme buffer (40 mM Hepes, 100 mM KCl, 0.5 mM
EDTA, 0.2 mg/ml BSA; pH 8.0), covered with 100l of
either buffer or FPG, sealed with a coverslip and incu-
bated for 30 min at 37 ◦C. Slides were then continued
with the electrophoresis till staining and scoring. FPG-
sensitive sites were calculated by subtracting the percent
DNA in tail obtained in the absence of enzyme from the
percent DNA in tail in the presence of enzyme.
2.7. RNA extraction
Total RNA from peripheral blood lympho-
cytes (∼5 × 106) was extracted using TRI reagent
(Sigma–Aldrich, India). To check the integrity of the
total RNA, 1g was fractionated on a 1% denaturing
agarose gel. RNA concentration was quantified spec-
trophotometrically and had a 280/260 OD ratio between
1.8 and 2.0.
2.8. RT-PCR
Total RNA (1g) was reverse transcribed in a 25l
reaction containing 5× reaction buffer, 0.2g ran-
dom hexamer primers (Qiagen Inc., USA), 200 units
murine leukemia virus reverse transcriptase (GE Health-Please cite this article in press as: Adaikalakoteswari, A., et al., Oxi
polymerase/nuclear factor-kappa B signaling in patients with Typ
Biochemistry and Cell Biology (2007), doi:10.1016/j.biocel.2007.0
care, USA), 2.5 mm dNTPs and 50 units Ribonuclease
inhibitor in a Thermocycler (Biorad, USA) (55 min at
37 ◦C, 5 min at 95 ◦C) (Dincer, Akcay, Alademir, &
Ilkova, 2003). PRESS
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The PARP mRNA expression PCR was probed using
specific primers; their sequence is 5′–3′ AAGCCC-
TAAAGGCTCAGAAC (nucleotide position 168–187)
and TTGGGTGTCTGTGTCTTGAC (465–485). The
conditions of amplification were: 94 ◦C for 1 min, 60 ◦C
for 1 min and 72 ◦C for 1 min for 24 cycles of amplifi-
cation. The number of cycles was determined to assure
that the amplification occurs in the exponential phase.
PCR products were separated by 2% agarose gel elec-
trophoresis. The housekeeping GAPDH PCR products
obtained by amplifying primers were used as an internal
control.
2.9. Evaluation PARP gene product
The PARP gene expression was quantified using BIO-
RAD gel documentation and semi-quantitative analysis
using its software. The ratio of PARP to GAPDH PCR
product, expressed as peak density, was used as an index
of PARP gene expression (in densitometric units).
2.10. Preparation of nuclear extract
Nuclear extracts were prepared as described before
(Hofmann et al., 1998). Proteinase inhibitors (leupeptin,
pepstatin, aprotinin) were included in each solution at
the concentrations suggested by the manufacturer. In
brief, 5 × 105 cells were lysed in 400l ice-cold buffer
A (10 mM Hepes (pH 8.0), 10 mM KCl, 100M EDTA,
100M EGTA, 500M DTT, PI) and incubated on ice
for 30 min. After incubation, 3%NP-40 is added and
centrifuged for 5 min at 13,000 rpm. The supernatant
was discarded and the nuclear pellet was resuspended
in 100l ice-cold buffer B (20 mM Hepes (pH 8.0),
400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 500M
DTT, PI), incubated on ice for 2 h, vortexing every
10–15 min and centrifuged for 5 min at 13,000 rpm. The
supernatant containing nuclear proteins was immedi-
ately quick-frozen at −80 ◦C. Protein concentration was
determined using a standard curve with bovine serum
albumin (BSA: 2–10g/ml) according to the Bradford
method.
2.11. Assay of PARP activity
For the assay, 100g of nuclear protein was used.dative DNA damage and augmentation of poly(ADP-ribose)
e 2 diabetes and microangiopathy, International Journal of
4.013
lated poly(ADP-ribose) onto histone-coated proteins in
a 96-well plate using PARP universal colorimetric assay
kit (Biotech-India, India), and expressed as units of
PARP/mg protein.
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.12. Electrophoretic mobility shift assay (EMSA)
EMSA was performed as described previously
Hofmann et al., 1998). Binding of NFB to 5′-
adiolabelled NFB consensus oligonucleotide (5′-AGT
GA GGG GAC TTT CCC AGG C-3′; approximately
0,000 cpm) was performed using 10g of nuclear
xtract in 20l of 5× binding buffer (50 mM Tris, pH
.5, 250 mM NaCl, 5 mM DTT, 5 mM EDTA, 25% glyc-
rol) containing 1g of poly(dI–dC) and 200 nCi of
2P-labelled probe incubated for 20 min at room tem-
erature. The binding complex was separated on a 5%
on-denaturing polyacrylamide gel and electrophoresed
n 1× TBE buffer (1 M Tris, 0.9 M boric acid, 0.01 M
DTA, pH 8.0) for 3 h at 150 V. The specificity of the
omplex was checked using 10 ng of anti-p65 and anti-
50 antibodies (Santa Cruz Biotechnology Inc., CA,
SA), forming a new larger DNA–protein–antibody
omplex. The antibody was incubated with the nuclear
rotein 30 min before the addition of the probe. For
ompetition studies, a cold competitor was added at
0–100-fold molar excess to the binding mixture, 10 min
efore the addition of the 32P-labelled probe. Follow-
ng electrophoresis, the gel was dried under vacuum (at
0 ◦C for 50 min) and exposed to an X-ray film. The
omplexes were quantified using BIORAD gel docu-
entation and semi-quantitative analysis was done using
ts software. The extent of NFB binding to the con-
ensus NFB probe was set at 100% for the control
roup.
.13. Lipid peroxidation
Plasma level of malonodialdehyde (MDA), a marker
f lipid peroxidation was measured by thiobarbituric acid
eactive substances (TBARS) by fluorescence methodol-
gy (Adaikalakoteswari, Balasubramanyam, & Mohan,
005; Yagi, 1976).
.14. Protein carbonyls
Carbonyl content was evaluated by the 2,4-dinitro-
henylhydrazine (DNPH) assay (Adaikalakoteswari,
alasubramanyam, Rema, & Mohan, 2006; Levine et
l., 1990).
.15. Statistical analysisPlease cite this article in press as: Adaikalakoteswari, A., et al., Oxi
polymerase/nuclear factor-kappa B signaling in patients with Typ
Biochemistry and Cell Biology (2007), doi:10.1016/j.biocel.2007.0
Comparisons between groups were performed using
npaired Student’s t-test. The criterion for significance
s p < 0.05. Pearson correlation was used to compare the
orrelation between DNA damage estimate and other PRESS
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variables. All the analyses were age adjusted. Risk
variables that had significant association with oxida-
tive DNA damage (FPG-sensitive sites) on univariate
regression, were included as independent variables in
multiple linear regression analysis. Care was taken to
avoid inter-correlated variables in the regression equa-
tion. All analysis was done using Windows-based SPSS
statistical package (Version 10.0, Chicago, IL).
3. Results
Table 1 shows the clinical characteristics of study sub-
jects. None of the diabetic patients had ketonuria or any
history of diabetic ketosis. Of the 80 Type 2 diabetic sub-
jects, 65% were on oral hypoglycemic agents (OHA)
and others (35%) were on OHA plus insulin. Diabetic
patients with and without microangiopathy had signif-
icantly higher fasting plasma glucose, HbA1c, systolic
and diastolic blood pressure, serum cholesterol, triglyc-
erides and carotid IMT compared to control subjects.
The mean (±S.E.) levels of thiobarbituric acid
reactive substances (TBARS) and protein carbonyls
(PCO), respectively were significantly (p < 0.05)
higher in diabetic patients with (19.24 ± 1.6 nM/ml;
0.87 ± 0.04 nm/mg protein) and without microan-
giopathy (17.84 ± 1.3; 0.81 ± 0.06) compared to
control subjects (10.04 ± 0.8; 0.6 ± 0.02) (Table 1).
The basal DNA damage (percentage of DNA in the
tail) (mean ± S.E.) was significantly (p < 0.05) higher
in diabetic patients with (21.34 ± 1.4) and without
(22.36 ± 1.6) microangiopathy compared to control
subjects (4.29 ± 1.04) (Fig. 1a). The FPG-sensitive
DNA-strand breaks which represent a reliable marker
of “oxidative DNA damage” (expressed as percent of
DNA in the tail (mean ± S.E.)) were also significantly
(p < 0.001) higher in diabetic patients with (19.41 ± 2.5)
and without microangiopathy (16.53 ± 2.0), when
compared to control subjects (1.38 ± 0.8) (Fig. 1b).
Correlation analysis showed that both in control
and diabetic subjects, the basal DNA damage were
significantly (p < 0.05) correlated with HbA1c, choles-
terol and triglyceride levels. While the oxidative DNA
damage showed no correlation with clinical param-
eters in control subjects, in diabetic patients they
were significantly and positively correlated to dura-
tion of diabetes (r = 0.53; p = 0.001), fasting (r = 0.44;
p = 0.005) and post-prandial (r = 0.54; p = 0.001) plasma
glucose, HbA1c (r = 0.34; p = 0.032), serum cholesteroldative DNA damage and augmentation of poly(ADP-ribose)
e 2 diabetes and microangiopathy, International Journal of
4.013
(r = 0.35; p = 0.025), triglycerides (r = 0.31; p = 0.049),
IMT (r = 0.41; p = 0.008), TBARS (r = 0.33; p = 0.037)
and PCO (r = 0.37; p = 0.019) levels and negatively cor-
related to creatinine clearance (r = −0.47; p = 0.007).
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Table 1
Clinical characteristics of the study subjects
Parameters Control
(n = 40)
Type 2 diabetes without
microangiopathy (n = 40)
Type 2 diabetes with
microangiopathy (n = 40)
Age (years) 45 ± 10 52 ± 9a 54 ± 9a
Sex (male %) 40 52 48
Duration of diabetes (years) 0 6 ± 6 9 ± 6b
Fasting plasma glucose (mmol/l) 88 ± 8 176 ± 8a 205 ± 66a
Glycated hemoglobin (%) 5.7 ± 0.6 8.9 ± 2.5a 9.5 ± 2.3a
Body mass index (kg/m2) 23 ± 4 24 ± 5 24 ± 3
Systolic blood pressure (mmHg) 118 ± 19 124 ± 25 134 ± 25a
Diastolic blood pressure (mmHg) 72 ± 11 75 ± 13 80 ± 12a
Serum cholesterol (mmol/l) 181 ± 32 197 ± 45 222 ± 60a
Serum triglycerides (mmol/l) 110 ± 49 183 ± 113 242 ± 208a
Serum HDL cholesterol (mmol/l) 43 ± 11 44 ± 10 41 ± 10
Serum LDL cholesterol (mmol/l) 116 ± 27 114 ± 35 121 ± 57
Cholesterol:HDL ratio 4.4 ± 1.0 4.6 ± 1.2 5.3 ± 1.4a,b
Intima-media thickness (mm) 0.76 ± 0.2 0.87 ± 0.2a 0.93 ± 0.2a
Creatinine clearance (ml/(min m2)) 89 ± 18 90 ± 25 83 ± 28
TBARS (nM/ml) 10.0 ± 5.1 17.8 ± 8.5a 19.2 ± 9.8a
PCO (nM/mg protein) 0.60 ± 0.1 0.81 ± 0.4a 0.87 ± 0.3aValues are expressed as mean ± S.D.
a p < 0.05 compared to controls.
b p < 0.05 compared to Type 2 diabetes without microangiopathy.
Fig. 2a is an illustration of mRNA gene expression
patterns of PARP and GAPDH in the study subjects.
PARP mRNA expression was significantly (p < 0.05)
increased in diabetic patients with (0.31 ± 0.03 densito-
metry units) and without (0.35 ± 0.02) microangiopathy
compared to control subjects (0.19 ± 0.02) (Fig. 2b).
Concurrent to mRNA findings, PARP activity was
also significantly (p < 0.05) increased in diabetic sub-
jects (0.42 ± 0.05) compared to controls (0.11 ± 0.02)
(Fig. 2c). Though PARP activity in diabetes subjects withPlease cite this article in press as: Adaikalakoteswari, A., et al., Oxi
polymerase/nuclear factor-kappa B signaling in patients with Typ
Biochemistry and Cell Biology (2007), doi:10.1016/j.biocel.2007.0
microangiopathy (0.22 ± 0.02) was lower than patients
without microangiopathy, it was significantly (p < 0.05)
higher than the activity levels seen in the control subjects.
NFB binding activity as measured from the EMSA
Fig. 1. (a) Basal DNA damage (mean ± S.E.) in (1) control subjects (4.29 ± 1
giopathy (21.34 ± 1.5). (b) FPG-sensitive DNA strand breaks (mean ± S.E.
(16.53 ± 2.0) and (3) with microangiopathy (19.41 ± 2.5). *p < 0.05 comparetechnique is illustrated in Fig. 3a. Diabetic subjects with
and without microangiopathy exhibited a significantly
(p < 0.05) higher (80%) NFB binding activity compared
to control subjects (Fig. 3b). In diabetic patients, oxida-
tive DNA damage also correlated positively with PARP
gene expression (r = 0.476; p = 0.002) (Fig. 4a), PARP
activity (r = 0.320; p = 0.044) (Fig. 4b) and NFB bind-
ing activity (r = 0.490; p = 0.001) (Fig. 4c). When age,
sex, smoking, presence of diabetes, HbA1c, cholesterol,
triglycerides, creatinine clearance, IMT, TBARS, PCO,dative DNA damage and augmentation of poly(ADP-ribose)
e 2 diabetes and microangiopathy, International Journal of
4.013
NFB binding activity, PARP gene expression and activ-
ity, were included as potential independent variables in
the forward regression analysis, presence of diabetes,
PARP activity, IMT, and creatinine clearance remained
.04), (2) diabetic subjects without (22.36 ± 1.6) and (3) with microan-
) in (1) control subjects (1.38 ± 0.85), (2) diabetic subjects without
d to control values.
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Fig. 2. (a) Representative illustration of gene expression patterns of PARP and GAPDH in control subjects (lanes 1–4), diabetic subjects without
microangiopathy (lanes 6–9) and diabetic subjects with microangiopathy (lanes 11–14). Lanes 5 and 10 show DNA ladder (100–700 bp). After
densitometric analysis, expression of PARP mRNA was adjusted for the expression of the housekeeping gene GAPDH. (b) Estimated PARP mRNA
expression (mean ± S.E.) for (1) control subjects, (2) diabetic subjects without and (3) with microangiopathy were 0.19 ± 0.02, 0.35 ± 0.02,
0.31 ± 0.03, respectively. (c) PARP activity (mean ± S.E., units/mg protein) for (1), (2) and (3) were 0.11 ± 0.02, 0.42 ± 0.05, 0022 ± 0.02,
respectively. *p < 0.05 compared to control values, # p < 0.05 compared to values in diabetic subjects without microangiopathy.
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hig. 3. (a) Representative illustration of NFB binding activity by EM
–7: Diabetic subjects without microangiopathy; lanes 8 and 9: diab
nalysis for NFB binding activity: estimated NFB binding activity i
3) with microangiopathy (186%).
n the final regression equation as risk variables arising
ut of oxidative DNA damage.
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Oxidative stress has been implicated in the pathogen-
sis of various chronic diseases including Type 2 diabetes
nd its complications. Evidence suggests a link among
yperglycemia, oxidative stress and reduced antioxidantnique. Lanes 1 and 4: free probe; lanes 2 and 3: control subjects; lanes
jects with microangiopathy. (b) Cumulative data after densitometric
ntrol subjects (set at 100%), (2) diabetic subjects without (182%) and
potential, but their relationship in clinical diabetes is
unclear. While intervention studies with classic antioxi-
dants such as vitamin E failed to demonstrate convincing
beneficial effects (Balasubramanyam, 2006; Ceriello,
2003), they do recommend that assessment of oxida-dative DNA damage and augmentation of poly(ADP-ribose)
e 2 diabetes and microangiopathy, International Journal of
4.013
tive damage should be done in epidemiological and
clinical studies. Despite a few studies, the subject of
oxidative stress in diabetes and its complications has
not been addressed in an epidemiological setting. The
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RP mR
etic subFig. 4. Correlation of FPG-sensitive DNA strand breaks with (a) PA
p = 0.044) and (c) NFB binding activity (r = 0.490; p = 0.001) in diab
absence of epidemiologic data on oxidative damage in
normal human populations represents a serious gap in
our knowledge about the distribution, correlates, and
causative factors of oxidative damage. Therefore, the
present study assumes significance for the following
reasons. First, oxidative damage to the macromolecules
(lipid, protein and DNA) was comprehensively assessed
in subjects from the epidemiological programme. Sec-
ondly, the study establishes a significant correlation
between oxidative DNA damage and a number of clini-
cal phenotypes associated with Type 2 diabetes. Thirdly,
molecular evidence for increased oxidative stress in clin-
ical diabetes and microangiopathy was provided through
a comprehensive analysis of oxidative DNA damage and
augmentation of PARP/NFB signals.
Research on the cellular effects of hyperglycemia
has elucidated several molecular defects among which
oxidative damage appears to represent a central abnor-
mality (Brownlee, 2001; Ceriello, 2003). Increased lipid
and protein oxidation have been demonstrated in both
experimental and clinical diabetes studies, with more
recent studies pointing to F2-isoprostane and nitrotyro-
sine emerging as useful biomarkers of oxidative stress
(Morrow, 2005; Pacher et al., 2005). Several studies
have also shown increased oxidative DNA damage (ChoiPlease cite this article in press as: Adaikalakoteswari, A., et al., Oxi
polymerase/nuclear factor-kappa B signaling in patients with Typ
Biochemistry and Cell Biology (2007), doi:10.1016/j.biocel.2007.0
et al., 2005; Dincer et al., 2003; Pitozzi, Giovannelli,
Bardini, Rotella, & Dolara, 2003; Sampson, Winterbone,
Hughes, Dozio, & Hughes, 2006) and accumulation of
8-OHdG (Hinokio et al., 1999; Shin et al., 2001; Speit,NA expression (r = 0.476; p = 0.002), (b) PARP activity (r = 0.320;
jects.
Schutz, Bonzheim, Trenz, & Hoffmann, 2004) in patients
with diabetes suggesting the involvement of hyper-
glycemia in oxidative DNA damage. Increased oxidative
damage related to mitochondrial DNA (mtDNA) alter-
ations was also reported in Type 2 diabetes (Speit et al.,
2004).
In many studies, DNA damage was assessed as DNA
strand breaks to look for endogenous oxidative dam-
age to DNA. However there are some limitations to
this approach: (a) breaks can arise in a variety of ways
unrelated to oxidation and (b) breaks are quite rapidly
repaired by cells (Collins, 2004; Lin et al., 2005; Speit et
al., 2004). In our study, we have used FPG to recognize
altered purines (including 8-oxo-guanine, the principal
substrate for FPG in vivo) and thereby estimated the
oxidative DNA damage. Oxidative DNA damage (FPG-
sensitive DNA strand breaks) in diabetic patients was
very well correlated to poor glycemic control (in terms
of fasting and post-prandial hyperglycemia and HbA1c)
suggesting that glucose toxicity may be the main culprit
contributing to enhanced oxidative stress. Since patients
with high blood glucose and high lipid levels are at an
increased risk for vascular damage, the results also sug-
gest that in the presence of chronic hyperglycemia and
hyperlipidemia, any increase in oxidative DNA damagedative DNA damage and augmentation of poly(ADP-ribose)
e 2 diabetes and microangiopathy, International Journal of
4.013
might serve as a reliable indicator of increased predilec-
tion to diabetic vascular complications.
The association of FPG-sensitive sites with lipid
peroxidation and protein carbonyl levels among the
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iabetic subjects in our study further substantiates the
nter-relationship between lipid-, protein- and nucleic
cid-damage and induction of the oxidative stress (Choi
t al., 2005). Additionally we also observed that both
xidative DNA damage and intimal thickening were
reater in diabetics. This is in consistent with the findings
n which oxidative DNA damage was associated with
uman atherosclerotic plaques that promote cell prolifer-
tion, hypertrophy, growth arrest and/or apoptosis (Irani,
000; Kunsch & Medford, 1999). Recently, Demirbag,
ilmaz, & Kocyigit (2005) also reported increased DNA
amage with severity of CAD and its risk factors.
In addition to oxidative DNA damage, our study
evealed increased PARP mRNA expression and activity
nd augmented NFB signaling in patients with Type
diabetes and microangiopathy. Evidence implicates
hat PARP is involved in the onset of pathophysiolog-
cal diseases at two different levels: (1) PARP acting as
sensor of DNA damage in cells and (2) PARP act-
ng as transcriptional co-activator of NFB (Hassa &
ottiger, 2002). Recent studies have delineated a role of
ARP-1 activation in the pathogenesis of diabetes and
iabetic complications including cardiovascular dys-
unction (Pacher et al., 2002), nephropathy (Wahlberg,
arlson, Wasserman, & Ljungqvist, 1985), neuropathy
Ilnytska et al., 2006; Li et al., 2004) and retinopathy
Zheng, Szabo, & Kern, 2004).
It is suggested that increased ROS play a critical
ole in signaling the cellular inflammatory response by
ctivating the redox-sensitive transcription factor, NFB
Kabe, Ando, Hirao, Yoshida, & Handa, 2005). In our
tudy, NFB binding activity was significantly increased
n cells from patients with diabetes and microangiopathy.
ore importantly, oxidative DNA damage as repre-
ented by FPG-sensitive sites was positively correlated
ith three different molecular parameters viz., PARP
RNA expression, PARP activity and NFB binding
ctivity. This emphasizes a tight link between oxidative
NA damage and augmented PPAR/NFB signaling in
atients with diabetes. Increased DNA binding affinity
f NFB in retinal endothelial cells exposed to high
lucose was demonstrated to be mediated via PARP
ctivity (Zheng et al., 2004) and binding of p50 subunit
o DNA was shown poly(ADP) ribosylation-dependent
Chang & Alvarez-Gonzalez, 2001). In addition, reduced
xpression of NFB dependent pro-inflammatory medi-
tors was reported in PARP-1(−/−) mice (Shall & de
urcia, 2000). Although DNA damage is considered asPlease cite this article in press as: Adaikalakoteswari, A., et al., Oxi
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n obligatory signal for PARP activation, it may also
ccur in the absence of DNA damage through the ERK2
athway (Cohen-Armon et al., 2007). Alternatively, the
ro-inflammatory cytokines often associate with dia- PRESS
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betes may also stimulate ERK/NFB signaling (Larsen
et al., 2005). Therefore, it appears that the NFB/PARP
interface might be a potential target to interrupt the
vicious cycle of oxidative stress and for the develop-
ment of new combinations of drugs disrupting specific
protein–protein interactions.
While a role for oxidative stress has been demon-
strated in the development of microangiopathy in
diabetic patients, the oxidative DNA damage seen in
diabetic subjects with microangiopathy was not signif-
icantly higher compared to that observed in diabetic
subjects without microangiopathy. It is unlikely to be
explained as a feedback control by DNA repair enzymes
because vascular complications were very often related
at the cellular level to augmentation of poly(ADP) ribo-
sylation and NFB events. The plausible explanation
for our results in diabetes patients with microangiopa-
thy may be related to drug regimen in these patients
in addition to glucose-lowering agents, which could
modulate DNA damage and interfere with PARP/NFB
signals (Martin-Ventura et al., 2005; Ohga et al., 2007;
Schmeisser et al., 2004; Shin et al., 2005). Alternatively,
reduced PARP activity may be influenced by angiogenic
milieu seen in microangiopathy conditions. For exam-
ple, insulin-like growth factor-I (IGF-I) has been shown
to promote angiogenesis by enhancing vascular endothe-
lial growth factor (VEGF) expression via suppression
of PARP activity (Beckert et al., 2006). However, these
causality relationships need to be tested in larger samples
and in prospective studies. Nevertheless, an increased
oxidative DNA damage and PARP activity seen in our
study in diabetic patients prior to the onset of vascu-
lar pathology is an important observation. Since PARP
activation was also shown in healthy subjects at risk of
developing diabetes as well as in established Type 2 dia-
betic patients (Szabo et al., 2002), these studies reveal
opportunities for early therapeutic intervention. More-
over, increased DNA damage in our diabetic patients
with microangiopathy compared to control subjects,
emphasize a role for oxidative stress in the develop-
ment and progression of microvascular complications. In
fact, urinary 8-OHG has been reported as a biomarker of
oxidative DNA damage in diabetic nephropathy patients
(Hinokio et al., 1999; Wu, Chiou, Chang, & Wu, 2004;
Xu et al., 2004) and higher serum 8-OHG levels were
reported in diabetic patients with advanced microvascu-
lar complications (Shin et al., 2001). While decreased
creatinine clearance is the earliest predictor of renaldative DNA damage and augmentation of poly(ADP-ribose)
e 2 diabetes and microangiopathy, International Journal of
4.013
dysfunction, it is important to note in our study, that
oxidative DNA damage was negatively correlated to cre-
atinine clearance in diabetic patients. We also noted that
the levels of oxidative DNA damage were significantly
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(p = 0.019) higher in patients with creatinine clearance
of less than 70 ml/min compared with those with values
greater than 70 ml/min. These observations warrant fur-
ther studies so as to relate causality of oxidative DNA
damage to the severity of diabetic microvascular com-
plications.
The demonstration of oxidative DNA damage and
augmentation of its downstream effectors in patients
with Type 2 diabetes and microangiopathy in this work
has several implications. Perhaps, this is one of the first
population-based studies in which oxidative DNA dam-
age was shown correlated to poor glycemic and lipid
status on one hand and to augmentation of PARP/NFB
signals on the other hand. It is of interest to note that
oxidative DNA damage in diabetes patients was not
only correlated to HbA1c levels but also more signif-
icantly to post-prandial plasma glucose levels. While
DCCT–EDIC outcomes (Hirsch & Brownlee, 2005)
claim glycemic variability in addition to HbA1c as a risk
factor for vascular complications, it has been recently
shown that acute glucose fluctuations triggered more
specific oxidative stress than sustained chronic hyper-
glycemia in patients with Type 2 diabetes (Monnier et al.,
2006). In view of emerging evidence that oxidative DNA
damage to be a biomarker in molecular epidemiologi-
cal studies (Dalle-Donne, Rossi, Colombo, Giustarini,
& Milzani, 2006; Heilbronn et al., 2006; Ilnytska et
al., 2006), development of new strategies designed to
detect DNA damage caused by oxidative stress may
advance our understanding of the roles of such types
of damage in the etiology of diabetes and its com-
plications. In fact, a DNA adduct detection method
(adductome approach) that uses liquid chromatogra-
phy coupled with electrospray ionization tandem mass
spectrometry (LC/ESI-MS/MS) to detect multiple DNA
adducts in human tissues as clinical biomarkers is also
underway (Kanaly et al., 2006).
One of the limitations of this work is that
being a cross-sectional study, a cause-and-effect rela-
tionship cannot be established. Nevertheless, it has
provided a molecular evidence for genomic instability
in patients with Type 2 diabetes and microangiopa-
thy in Asian Indians. Asian Indians with Type 2
diabetes also exhibit decreased HDL (Misra, Luthra,
& Vikram, 2004), hypoadiponectinemia (Mohan et
al., 2005), hypoglutathionemia (Sampathkumar et
al., 2005; Sampathkumar, Balasubramanyam, Tara,
Rema, & Mohan, 2006), impaired antioxidant defensePlease cite this article in press as: Adaikalakoteswari, A., et al., Oxi
polymerase/nuclear factor-kappa B signaling in patients with Typ
Biochemistry and Cell Biology (2007), doi:10.1016/j.biocel.2007.0
(Adaikalakoteswari et al., 2006), shortened telomeres
(Adaikalakoteswari et al., 2005; Adaikalakoteswari,
Balasubramanyam, Ravikumar, Deepa, & Mohan, 2007)
and increased premature mortality rates (Mohan et al., PRESS
Biochemistry & Cell Biology xxx (2007) xxx–xxx
2006) all of which represent a state of increased oxida-
tive stress and genomic instability. In this context, our
work demonstrating increased oxidative DNA damage
in Type 2 diabetic patients warrants further studies on
the molecular aspects of both nuclear and mtDNA alter-
ations which could ultimately lead to novel drugs and
newer therapeutic options.
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